Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AMIFOSTINE

AMIFOSTINE

Standard Dose
500MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AMIFOSTINE is listed in Drugs@FDA under application 204363 (ANDA).

Marketing status: Discontinued Active ingredient AMIFOSTINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor EUGIA PHARMA SPECLTS Submission history Latest submission status date: 2017-07-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMIFOSTINE is listed in Drugs@FDA under application 204363 (ANDA). Marketing status: Discontinued Active ingredient AMIFOSTINE Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor EUGIA PHARMA SPECLTS Submission history Latest submission status date: 2017-07-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.